acyclovir

Generic: acyclovir

Labeler: slate run pharmaceuticals, llc
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name acyclovir
Generic Name acyclovir
Labeler slate run pharmaceuticals, llc
Dosage Form INJECTION, SOLUTION
Routes
INTRAVENOUS
Active Ingredients

acyclovir sodium 50 mg/mL

Manufacturer
Slate Run Pharmaceuticals, LLC

Identifiers & Regulatory

Product NDC 70436-030
Product ID 70436-030_1280dbca-a2d7-49cf-e063-6394a90a7596
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA218111
Listing Expiration 2026-12-31
Marketing Start 2024-03-01

Pharmacologic Class

Classes
dna polymerase inhibitors [moa] herpes simplex virus nucleoside analog dna polymerase inhibitor [epc] herpes zoster virus nucleoside analog dna polymerase inhibitor [epc] herpesvirus nucleoside analog dna polymerase inhibitor [epc] nucleoside analog [ext]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 70436030
Hyphenated Format 70436-030

Supplemental Identifiers

RxCUI
1734932
UNII
927L42J563

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name acyclovir (source: ndc)
Generic Name acyclovir (source: ndc)
Application Number ANDA218111 (source: ndc)
Routes
INTRAVENOUS
source: ndc

Resolved Composition

Strengths
  • 50 mg/mL
source: ndc
Packaging
  • 10 VIAL, SINGLE-DOSE in 1 CARTON (70436-030-82) / 10 mL in 1 VIAL, SINGLE-DOSE
source: ndc

Packages (1)

70436-030-82 10 VIAL, SINGLE-DOSE in 1 CARTON (70436-030-82) / 10 mL in 1 VIAL, SINGLE-DOSE

Ingredients (1)

acyclovir sodium (50 mg/mL)

Linked Drug Pages (1)

acyclovir ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["INTRAVENOUS"], "spl_id": "1280dbca-a2d7-49cf-e063-6394a90a7596", "openfda": {"unii": ["927L42J563"], "rxcui": ["1734932"], "spl_set_id": ["889bccd1-3793-40ce-bca2-c8c9cf6b7488"], "manufacturer_name": ["Slate Run Pharmaceuticals, LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "10 VIAL, SINGLE-DOSE in 1 CARTON (70436-030-82)  / 10 mL in 1 VIAL, SINGLE-DOSE", "package_ndc": "70436-030-82", "marketing_start_date": "20240301"}], "brand_name": "acyclovir", "product_id": "70436-030_1280dbca-a2d7-49cf-e063-6394a90a7596", "dosage_form": "INJECTION, SOLUTION", "pharm_class": ["DNA Polymerase Inhibitors [MoA]", "Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Nucleoside Analog [EXT]"], "product_ndc": "70436-030", "generic_name": "acyclovir", "labeler_name": "Slate Run Pharmaceuticals, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "acyclovir", "active_ingredients": [{"name": "ACYCLOVIR SODIUM", "strength": "50 mg/mL"}], "application_number": "ANDA218111", "marketing_category": "ANDA", "marketing_start_date": "20240301", "listing_expiration_date": "20261231"}